InSilico Medicine (HKG:3696) Chairman Aleksandrs Zavoronkovs plans to purchase additional shares of the company this month, allocating up to HK$16 million, according to a Friday bourse filing.
Zavoronkovs will purchase the shares in the secondary market using his personal funds, the biotech firm said.